serds at the inflection point in pretreated er /her2- breast cancer: novel er-targeting therapies
Published 2 years ago • 752 plays • Length 1:16:18Download video MP4
Download video MP3
Similar videos
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
32:54
raising the bar in her2-positive breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
1:31:37
personalizing treatment decisions in her2-altered breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
4:14
evo-ed: breast cancer and the her2 gene
-
5:41
what does her2 positive mean
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
49:50
breast cancer advances in research & treatment
-
1:20:02
her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients
-
1:03:35
the impact of targeted estrogen receptor (er) imaging on breast cancer patients
-
3:24
her2 testing in gastroesophageal cancers
-
1:17
key trial updates in serds in er /her2- breast cancer from sabcs 2022
-
1:34:19
drs. schalper, press, tarantino & wainberg discuss #her2, #her3, & #trop2: https://bit.ly/37bh4ek
-
1:25:22
a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
-
1:33:57
evaluating the evidence and parsing the practicalities of therapeutic choices in hr breast cancer
-
1:12
dr. rao on treatment de-escalation in hr /her2- breast cancer
-
1:40:47
clarifyingcomplexities of expandingtreatmentoptionsfor advancedandearly-stage hr /her2- breastcancer
-
3:41
diagnosis of her2 /er- early breast cancer